HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors

Clinical trial NCT06822998 · RECRUITING

Trial details

NCT number: NCT06822998
Sponsor: HighField Biopharmaceuticals Corporation
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-06-11
Primary completion: 2026-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.